JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB261716

Human NKX2-5 knockout HEK-293 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

NKX2-5 KO cell lysate available now. KO validated by Next Generation Sequencing, Western blot. Free of charge wild type control included. Knockout achieved by CRISPR/Cas9; X = 16 bp deletion, 5 bp deletion; Frameshift = 99.66%.
2 Images
Western blot - Human NKX2-5 knockout HEK-293 cell lysate (AB261716)
  • WB

Lab

Western blot - Human NKX2-5 knockout HEK-293 cell lysate (AB261716)

Lane 1 : Wild-type HEK-293 cell lysate 20 μg
Lane 2 : NKX2-5 knockout HEK-293 cell lysate 20 μg
Lane 3 : HeLa cell lysate 20 μg
False colour image of Western blot : Anti-Nkx2.5 antibody [EPR20168] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab205263 was shown to bind specifically to Nkx2.5. A band was observed at 40, 30, 25 kDa in wild-type HEK-293 cell lysates with no signal observed at this size in NKX2-5 knockout cell line ab261899 (knockout cell lysate ab261716). Bands at 37 and 35 kDa are non-specific believed to be NKX2-2 and NKX2-6. To generate this image, wild-type and NKX2-5 knockout HEK-293 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-Nkx2.5 antibody [EPR20168] (<a href='/en-us/products/primary-antibodies/nkx25-antibody-epr20168-ab205263'>ab205263</a>) at 1/1000 dilution

Lane 1:

Wild-type HEK-293 cell lysate at 20 µg

Lane 2:

NKX2-5 knockout HEK-293 cell lysate at 20 µg

Lane 2:

Western blot - Human NKX2-5 knockout HEK-293 cell line (<a href='/en-us/products/cell-lines/human-nkx2-5-knockout-hek-293-cell-line-ab261899'>ab261899</a>)

Lane 3:

HeLa cell lysate at 20 µg

Predicted band size: 35 kDa

Observed band size: 25 kDa,30 kDa,40 kDa

false

Next Generation Sequencing - Human NKX2-5 knockout HEK-293 cell lysate (AB261716)
  • NGS

Supplier Data

Next Generation Sequencing - Human NKX2-5 knockout HEK-293 cell lysate (AB261716)

Knockout achieved by CRISPR/Cas9; X = 16 bp deletion, 5 bp deletion; Frameshift = 99.66%

Key facts

Cell type

HEK-293

Species or organism

Human

Tissue

Kidney

Knockout validation

Next Generation Sequencing,Western blot

Mutation description

Knockout achieved by CRISPR/Cas9; X = 16 bp deletion, 5 bp deletion; Frameshift = 99.66%

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab261716-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human NKX2-5 knockout HEK293 cell lysate", "number":"AB261716-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK-293 cell lysate", "number":"AB261716-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
NKX2-5
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Next Generation Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Nkx2.5 also known as NKX2-5 or CSX is a homeobox-containing transcription factor with a molecular mass of approximately 35 kDa. It is primarily expressed in the heart specifically in cardiac progenitor cells and also found in low levels in the spleen stomach and pancreas. As a transcription factor Nkx2.5 plays a significant role in regulating the expression of genes critical for cardiac development and differentiation. The protein's expression is tightly regulated during early embryogenesis and maintained in the heart throughout life.
Biological function summary

Nkx2.5 functions to direct the development of cardiac myocytes by regulating genes involved in cell specification and tissue formation. Nkx2.5 does not solely operate but interacts with other cardiac-specific transcription factors such as GATA4 and TBX5 collectively forming a transcriptional complex. This cooperative interaction is essential in orchestrating the genetic program necessary for heart morphogenesis and cellular proliferation within the developing myocardium.

Pathways

The protein Nkx2.5 significantly influences cardiogenesis and heart formation pathways. Its activity is necessary in the Wnt signaling pathway important for the initial stages of cardiac cell lineage differentiation. Additionally Nkx2.5 works in tandem with the protein MEF2C to regulate cardiac-specific genes ensuring the proper development and functioning of cardiac tissues. Both pathways highlight important regulatory networks where Nkx2.5 is an important player in heart development.

Mutations or dysregulations of Nkx2.5 can lead to congenital heart defects such as atrial septal defects and tetralogy of Fallot. These conditions often arise due to disrupted genetic signaling during heart formation. Nkx2.5 mutations have been associated with conduction system defects in conjunction with the GATA4 protein both known to be involved in maintaining normal cardiac structure and function. Understanding Nkx2.5's role in these diseases aides in developing potential therapeutic approaches targeting congenital heart abnormalities.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com